Raymond James Financial
NXL icon

Raymond James Financial’s Nexalin Technology NXL Stock Holding History

Raymond James Financial’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.99K Hold
403
– – ﹤0.01% 5386
2026
Q1 		$4.21K Buy
+403
New +$6.29K ﹤0.01% 5274

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Raymond James Financial's NXL Position: Q2 2026 in Review

Raymond James Financial held its Nexalin Technology (NXL) position steady in Q2 2026 at 403 shares worth $3.99K. The position accounts for ﹤0.01% of the portfolio, ranked #5386.

Raymond James Financial first reported a position in NXL in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.21K in Q1 2026. 20 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

  • Raymond James Financial held 403 shares of Nexalin Technology worth $3.99K as of Q2 2026.
  • Raymond James Financial left its Nexalin Technology share count unchanged in Q2 2026.
  • Nexalin Technology made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5386 holding.
  • Raymond James Financial first reported a position in Nexalin Technology in Q1 2026 and has held it in 2 quarters since.
  • Raymond James Financial's Nexalin Technology position peaked at $4.21K in Q1 2026.
  • 20 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.